首页> 外文OA文献 >4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study
【2h】

4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study

机译:paI-1基因的4G / 5G多态性与肺炎引起的严重脓毒症的多器官功能障碍和感染性休克相关:前瞻性,观察性,遗传学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: Activation of inflammation and coagulation are udclosely related and mutually interdependent in sepsis. The udacute-phase protein, plasminogen activator inhibitor-1 (PAI-1) udis a key element in the inhibition of fibrinolysis. Elevated udlevels of PAI-1 have been related to worse outcome in pneumonia. udWe aimed to evaluate the effect of functionally relevant 4G/5G udpolymorphism of PAI-1 gene in pneumonia induced sepsis. Methods: udWe enrolled 208 Caucasian patients with severe sepsis due to udpneumonia admitted to an intensive care unit (ICU). Patients udwere followed up until ICU discharge or death. Clinical data udwere collected prospectively and the PAI-1 4G/5G polymorphism udwas genotyped by polymerase chain reaction-restriction fragment udlength polymorphism technique. Patients were stratified udaccording to the occurrence of multiple organ dysfunction udsyndrome, septic shock or death. Results: We found that carriers udof the PAI-1 4G/4G and 4G/5G genotypes have a 2.74-fold higher udrisk for multiple organ dysfunction syndrome (odds ratio [OR] ud95% confidence interval [CI] = 1.335 -5.604; p = 0.006) and a ud2.57-fold higher risk for septic shock (OR 95% CI = 1.180 - ud5.615; p = 0.018) than 5G/5G carriers. The multivariate logistic udregression analysis adjusted for independent predictors, such as udage, nosocomial pneumonia and positive microbiological culture udalso supported that carriers of the 4G allele have a higher udprevalence of multiple organ dysfunction syndrome (adjusted odds udratio [aOR] = 2.957; 95% CI = 1.306 -6.698; p = 0.009) and udseptic shock (aOR = 2.603; 95% CI = 1.137 - 5.959; p = 0.024). udHowever, genotype and allele analyses have not shown any udsignificant difference regarding mortality in models non-udadjusted or adjusted for acute physiology and chronic health udevaluation (APACHE) II. Patients bearing the 4G allele had udhigher disseminated intravascular coagulation (DIC) score at udadmission (p = 0.007) than 5G/5G carriers. Moreover, in 4G udallele carriers the length of ICU stay of non-survivors was udlonger (p = 0.091), fewer ventilation-free days (p = 0.008) and uddays without septic shock (p = 0.095) were observed during the udfirst 28 days. Conclusions: In Caucasian patients with severe udsepsis due to pneumonia carriers of the 4G allele of PAI-1 udpolymorphism have higher risk for multiple organ dysfunction udsyndrome and septic shock and in agreement they showed more udfulminant disease progression based on continuous clinical udvariables.
机译:简介:脓毒症中炎症和凝血的激活密切相关且相互依赖。 uucute相蛋白,纤溶酶原激活物抑制剂-1(PAI-1)是抑制纤维蛋白溶解的关键因素。 PAI-1的升高水平与肺炎的预后较差有关。我们旨在评估PAI-1基因功能相关的4G / 5G多态性在肺炎引起的败血症中的作用。方法: ud我们招募了208名因 udp肺炎而入院的重症脓毒症高加索病房(ICU)。随访患者直至ICU出院或死亡。前瞻性收集临床数据,并通过聚合酶链反应-限制性片段 udlength多态性技术对PAI-1 4G / 5G多态性进行基因分型。根据多器官功能障碍,尿道综合症,败血性休克或死亡的发生情况对患者进行分层。结果:我们发现PAI-1 4G / 4G和4G / 5G基因型的携带者udud多器官功能障碍综合征的罹患风险高2.74倍(赔率[OR] ud95%置信区间[CI] = 1.335-与5G / 5G运营商相比,败血性休克的风险高(ud = 5.604; p = 0.006) ud2.57倍(OR 95%CI = 1.180- ud5.615; p = 0.018)。根据独立预测因素(例如,感染,医院内肺炎和阳性微生物培养)调整的多因素logistic回归分析也支持4G等位基因携带者具有更高的多器官功能障碍综合征患病率(校正后的优势比) 2.957; 95%CI = 1.306 -6.698; p = 0.009)和消化性休克(aOR = 2.603; 95%CI = 1.137-5.959; p = 0.024)。 然而,基因型和等位基因分析并未显示出在未经 uadjusted或针对急性生理和慢性健康 udevaluation(APACHE)II调整过的模型中,死亡率方面没有任何显着差异。携带4G等位基因的患者在入院时的弥散性血管内凝血(DIC)评分高于5G / 5G携带者(p = 0.007)。此外,在4G udallele载体中,非幸存者的ICU停留时间更长(p = 0.091),在通气期间观察到更少的无通气天数(p = 0.008)和没有感染性休克的udday(p = 0.095)。 ud头28天。结论:在白种人中,由于PAI-1 4G等位基因的肺炎携带者而导致严重的尿毒症多态性多发性器官功能障碍尿道综合征和败血性休克的风险较高,并且基于持续的临床多变的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号